Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y. Ge, Kornélia Polyák, Katherine C. Murphy et al.|Nature Communications|2020Cited by 97
Abstract 4578: Development of a rapid clinical grade assay to detect and monitor secondary <i>KIT</i> mutations in circulating free DNA (cfDNA) for personalization of targeted therapy for gastrointestinal stromal tumors (GIST)Adrián Mariño‐Enríquez, Yanan Kuang, Suzanne George et al.|Cancer Research|2018Cited by 0